Ran Reshef1. Show Affiliations » 1. University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract
Mesh: See more » Acute DiseaseAntineoplastic Combined Chemotherapy Protocols/therapeutic useBiomarkers/bloodChronic DiseaseGraft vs Host Disease/immunologyGraft vs Host Disease/mortalityGraft vs Host Disease/pathologyGraft vs Host Disease/prevention & controlGraft vs Leukemia EffectHLA Antigens/bloodHumansImmunosuppressive Agents/therapeutic useLeukemia/therapyLymphocyte DepletionLymphoma/therapyMyelodysplastic Syndromes/therapySeverity of Illness IndexSex FactorsStem Cell TransplantationSurvival RateT-Lymphocytes/drug effectsT-Lymphocytes/immunologyT-Lymphocytes/pathologyTransplantation, HomologousUnrelated Donors
Substances: See more » BiomarkersHLA AntigensImmunosuppressive Agents
Year: 2012 PMID: 23187772
Source DB: PubMed Journal: Clin Adv Hematol Oncol ISSN: 1543-0790